Search Results - V. S. Kosorukov
- Showing 1 - 13 results of 13
-
1
Using short tandem repeat profiling to validate cell lines in biobanks by E. N. Kosobokova, A. A. Malchenkova, N. A. Kalinina, V. S. Kosorukov
Published 2022-12-01Aim. To approve the COrDIS kit (Gordiz, Russia) for the authenticity of cell lines from the Bioresource Collection of the N.N. Blokhin National Medical Research Center of Oncology by the short tandem repeat (STR) profiling.Material and methods. The chosen method proved to be a reliable and reproduci...
Get full text
Article -
2
Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials by V. S. Kosorukov, G. R. Abuzarova, E. R. Zakharochkina, O. Yu. Gamzeleva, K. A. Yatsenko
Published 2022-08-01Introduction. pain syndrome significantly affects quality of life and daily activities of patients with cancer, especially at terminal stages of the disease. Opioid analgesics are considered the “gold standard” of therapy, but their use is associated with bureaucratic difficulties, as well as risk o...
Get full text
Article -
3
Bioresource collections: algorithms for development and functioning; basic and applied significance by E. N. Kosobokova, N. A. Kalinina, M. A. Baryshnikova, V. S. Pokrovsky, O. N. Solopova, T. A. Bogush, V. S. Kosorukov
Published 2023-12-01Bioresource collection of the N. N. Blokhin National Medical Research Center of Oncology is a unique structured biobank that combines different types of primary and subsidiary samples and ensures its comprehensive characterization, including both generally accepted indicators and specific types of r...
Get full text
Article -
4
A Panel of Cultures of Cancer and Normal Lung Cells with a Characterized Expression of PD-L1 to Search and Development of the Target Modifiers of Immunotherapy by T. A. Bogush, A. N. Grishanina, A. M. Scherbakov, D. A. Khochenkov, R. Yu. Yunusova, S. A. Kalyuzhny, V. S. Kosorukov
Published 2024-11-01Background. The search for effective combinations of immune checkpoint inhibitors with common cytostatics, targeted cancer drugs and other treatments is a modern trend to improve the effectiveness of immunotherapy.Purpose. Development of a panel of lung cancer cell cultures and cells of normal lung ti...
Get full text
Article -
5
Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer by T. A. Bogush, P. D. Potselueva, A. M. Scherbakov, E. A. Bogush, A. B. Ravcheeva, N. O. Vikhlyantseva, V. S. Kosorukov
Published 2023-07-01Background. Estrogen receptors beta (ERβ) are an important biological regulator and target of antiestrogens, however, unlike estrogen receptors alpha (ERɑ), their significance in the prognosis and treatment of breast cancer remains unclear. Purpose. Evaluation of the ERβ prognostic value in the comp...
Get full text
Article -
6
Expression of the cytoskeletal proteins – cytokeratins and beta-III tubulin in human melanoma cell lines from the collection of N. N. Blokhin National Medical Research Center of On... by T. A. Bogush, I. E. Mizaeva, A. A. Basharina, A. N. Grishanina, M. A. Baryshnikova, O. S. Burova, A. A. Rudakova, V. S. Kosorukov
Published 2023-10-01Introduction. Despite advances in the treatment of melanoma, the results of therapy cannot be considered satisfactory, and the search for new drugs and effective combinations of medicine continues. The drugs are being developed aimed at reducing the metastatic tumor potential – migrastatics. The tar...
Get full text
Article -
7
Molecular characteristics of non-small cell lung cancer tissue based on quantitative indicators of progesterone receptors expression by I. P. Romanov, T. A. Bogush, A. M. Scherbakov, A. A. Alimov, E. A. Bogush, A. B. Ravcheeva, A. Lee, V. S. Kosorukov
Published 2024-04-01Background. Progesterone receptors (PR) are regulators of cell proliferation and therefore can be considered as an aim for targeted medications in the treatment of oncological diseases. At the same time, a quantitative assessment of PR expression in the tissue of non-small cell lung cancer (NSCLC),...
Get full text
Article -
8
Characterization of Non-Small Cell Lung Cancer Tissue by Quantitative Assessment of Class III β-Tubulin Expression by A. Lee, T. A. Bogush, A. N. Grishanina, I. P. Romanov, E. A. Bogush, S. A. Kaliuzhny, K. I. Chandran, A. M. Scherbakov, V. S. Kosorukov
Published 2024-10-01Background. The cytoskeletal protein β-tubulin class III (Tubb3) is associated with tumor resistance to taxanes and vinca alkaloids, as well as with the metastatic potential of neoplasm, however, data from immunohistochemical analysis of Tubb3 expression in non-small cell lung cancer (NSCLC) tissue...
Get full text
Article -
9
Correlation of quantitative measures of estrogen receptor α and β expression in non-small cell lung cancer tissue with clinical characteristics of the disease by T. A. Bogush, S. A. Samsonik, A. A. Basharina, E. A. Bogush, O. M. Ryabinina, A. N. Grishanina, V. Yu. Kirsanov, A. V. Karpukhin, V. S. Kosorukov
Published 2021-08-01The expression level of estrogen receptors (ERα and ERβ) in surgical tumor biopsy specimens from 167 patients with non-small cell lung cancer (NSCLC) was quantified by flow cytometry-based immunofluorescence analysis. ERα and ERβ expression was revealed in all the tumor samples investigated. The level...
Get full text
Article -
10
Survival Outcomes in Patients after Radical Surgery for Non-Small Lung Cancer: an 8-year Study at N. N. Blokhin Cancer Research Center by Т. А. Bogush, Е. А. Rukavishnikova, А. А. Basharina, Е. А. Bogush, V. Yu. Kirsanov, S. D. Kolomiytsev, А. В. Ravcheeva, N. О. Vikhlyantseva, V. S. Kosorukov
Published 2021-05-01In the study of 125 patients after radical surgery for non-small cell lung cancer (NSCLC), distinctive clinicopathological parameters of this disease were found. Thus, the majority of patients with NSCLC were smokers (73%), men had significantly higher rate of the disease than women (80% vs 20%). Pat...
Get full text
Article -
11
Study of Ridostin Pro and Poly(I:C) as adjuvants that enhance the immunogenicity of an antitumor vaccine by A. V. Ponomarev, P. V. Tsarapaev, M. A. Baryshnikova, Z. A. Sokolova, A. A. Rudakova, M. V. Mironova, D. V. Gusev, G. M. Levagina, E. D. Danilenko, V. S. Kosorukov
Published 2024-07-01Aim of the study: to compare the antitumor efficacy and immunogenicity of vaccines with the same antigens but different adjuvants: Ridostin Pro or Poly(I:C); to evaluate the effect of Ridostin Pro and Poly(I:C) on the cytokine profile of serum and the immunophenotype of mouse spleen cells. Material...
Get full text
Article -
12
Features of Sulfide Mineralization of the Hydrothermal System of Cape Fiolent (Southwestern Crimea) by N. V. Lubnina, O. V. Krylov, A. Yu. Bychkov, I. N. Modin, A. D. Skobelev, E. V. Kozlova, V. L. Kosorukov, M. V. Kosnyreva, N. I. Kosevich, A. Yu. Palenov
Published 2024-06-01As a result of generalization of geophysical studies, petro-paleomagnetic and structural-geomorphological analyses, as well as thermodynamic modeling, some features of ore formation in the hydrothermal system of Cape Fiolent (southwestern Crimea) under island arc conditions were revealed.It has been...
Get full text
Article -
13
Repetition of the Void Space Structure of Achimov Sandstones of the East Urengoyskoye Field in Artificially Created Geometry of a Silicon Microfluidic Chip by М. R. Latypova, D. I. Pereponov, V. V. Kazaku, А. Scerbacova, I. G. Maryasev, R. А. Mukhin, Е. D. Shilov, А. N. Cheremisin, V. L. Kosorukov, V. V. Churkina, М. А. Tarkhov, V. А. Shtinov, Т. E. Nigmatullin, E. S. Batyrshin, I. V. Samsonov
Published 2025-04-01In this work, a unique technique for replicating the void structure of a low-permeability reservoir in a silicon microfluidic chip has been developed. This technique is qualitatively superior to all previous ones and provides full repeatability of key parameters of the void structure (permeability;...
Get full text
Article